GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chabiotech Co Ltd (XKRX:085660) » Definitions » Cyclically Adjusted Revenue per Share

Chabiotech Co (XKRX:085660) Cyclically Adjusted Revenue per Share : ₩14,174.40 (As of Mar. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Chabiotech Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Chabiotech Co's adjusted revenue per share for the three months ended in Mar. 2024 was ₩4,123.045. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₩14,174.40 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Chabiotech Co's average Cyclically Adjusted Revenue Growth Rate was 7.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 6.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 5.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Chabiotech Co was 6.90% per year. The lowest was 0.10% per year. And the median was 3.90% per year.

As of today (2024-06-19), Chabiotech Co's current stock price is ₩16550.00. Chabiotech Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ₩14,174.40. Chabiotech Co's Cyclically Adjusted PS Ratio of today is 1.17.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Chabiotech Co was 3.79. The lowest was 0.95. And the median was 1.37.


Chabiotech Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Chabiotech Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chabiotech Co Cyclically Adjusted Revenue per Share Chart

Chabiotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10,961.50 11,405.00 12,312.10 12,926.40 13,943.60

Chabiotech Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13,208.10 13,362.00 13,782.90 13,943.60 14,174.40

Competitive Comparison of Chabiotech Co's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, Chabiotech Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chabiotech Co's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chabiotech Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Chabiotech Co's Cyclically Adjusted PS Ratio falls into.



Chabiotech Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Chabiotech Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=4123.045/118.8477*118.8477
=4,123.045

Current CPI (Mar. 2024) = 118.8477.

Chabiotech Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 1,390.626 99.353 1,663.490
201409 1,329.077 99.608 1,585.794
201412 2,749.589 99.098 3,297.567
201503 18,237.522 99.720 21,735.735
201506 1,959.208 100.050 2,327.310
201509 2,097.879 100.110 2,490.541
201512 2,176.010 100.220 2,580.461
201603 2,201.648 100.560 2,602.037
201606 2,219.815 100.790 2,617.521
201609 2,291.202 101.460 2,683.857
201612 2,595.612 101.560 3,037.441
201703 1,892.360 102.850 2,186.705
201706 1,855.492 102.610 2,149.118
201709 1,863.651 103.490 2,140.213
201712 2,858.400 102.990 3,298.517
201803 2,239.289 104.100 2,556.526
201806 1,230.398 104.130 1,404.302
201809 1,768.574 105.650 1,989.503
201812 2,428.427 104.350 2,765.817
201903 2,785.941 104.490 3,168.750
201906 2,473.549 104.880 2,802.971
201909 2,131.404 105.200 2,407.913
201912 2,362.973 105.120 2,671.555
202003 2,938.382 105.540 3,308.887
202006 4,166.386 104.870 4,721.707
202009 6,268.280 106.200 7,014.790
202012 2,476.784 105.765 2,783.142
202103 3,210.438 107.357 3,554.053
202106 3,608.543 107.579 3,986.546
202109 3,460.621 108.759 3,781.628
202112 3,405.677 109.676 3,690.465
202203 3,345.756 111.806 3,556.483
202206 673.506 114.083 701.636
202209 3,850.199 114.831 3,984.866
202212 4,071.659 115.200 4,200.577
202303 3,581.235 116.550 3,651.849
202306 3,985.515 117.140 4,043.620
202309 4,211.956 119.111 4,202.638
202312 4,274.856 118.848 4,274.856
202403 4,123.045 118.848 4,123.045

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Chabiotech Co  (XKRX:085660) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Chabiotech Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=16550.00/14174.4
=1.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Chabiotech Co was 3.79. The lowest was 0.95. And the median was 1.37.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Chabiotech Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Chabiotech Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Chabiotech Co (XKRX:085660) Business Description

Industry
Traded in Other Exchanges
N/A
Address
151-21 Buk-Ni Namsa-Myun, Cheoin-Gu, Yongin, Gyeonggi, KOR, 449-884
Chabiotech Co Ltd is engaged in the manufacturing of biological products.

Chabiotech Co (XKRX:085660) Headlines

No Headlines